Breadcrumb Navigation

The co-expression of CD26 and TGF-β1 renders lung cancer targetable to CD26-inhibition

News aus dem Fachbereich

03. August 2019

Congratulations to Wolfgang Jungraithmayr for receiving the price "B. Braun Award to N. Enz and W. Jungraithmayr, 54th annual meeting of the ESSR"​ for his work on The co-expression of CD26 and TGF-β1 renders lung cancer targetable to CD26-inhibition.

Wolfgang Jungraithmayr, Prof. Dr. Dr. med.

Forschungsgruppenleiter , Klinik für Thoraxchirurgie

Behandelnder Fachbereich

Klinik für Thoraxchirurgie